Hepatitis C, Transarterial Embolization Versus Symptomatic Treatment in Patients With Advanced Hepatocellular Carcinoma, Current Information On Hepatitis C & treatments for the medical professional and patient.
Transarterial Embolization Versus Symptomatic Treatment in
Patients With Advanced Hepatocellular Carcinoma:
Results of a Randomized, Controlled Trial in a Single Institution
table 2. Causes of Death
|
|
|
TAE Group (n = 40) |
Control Group (n = 40) |
|
Tumor progression |
25 (83%) |
28 (93%) |
Gastrointestinal bleeding |
4 (13%) |
1 (3%) |
Hepatic failure |
1 (3%) |
1 (3%) |
|
|
[Return To Article]